Rallybio Corporation (RLYB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $93.6M, listed on NASDAQ, employing roughly 9 people, carrying a beta of -0.89 to the broader market. Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Led by Stephen Uden, public since 2021-07-29.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for RLYB as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →